Teva Pharmaceutical Industries Limited To Cough Up $565 Million In Israeli Taxes

Published: Nov 12, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Teva Pharmaceutical Industries (TEVA.TA) will pay 2 billion shekels ($565 million) to Israel's government as part of a program to release so-called trapped profit in exchange for a steep discount on its tax bill, the company said on Monday. Trapped profit is profit earned by multinationals after they had been provided with tax breaks to invest in Israel. The Finance Ministry is seeking to give the firms incentives to repatriate some of this profit and generate tax revenue for the government.

Help employers find you! Check out all the jobs and post your resume.

Back to news